Moriya, K.; Sato, S.; Nishimura, N.; Kawaratani, H.; Takaya, H.; Kaji, K.; Namisaki, T.; Uejima, M.; Nagamatsu, S.; Matsuo, H.;
et al. Efficacy of Serum Ferritin–Zinc Ratio for Predicting Advanced Liver Fibrosis in Patients with Autoimmune Hepatitis. J. Clin. Med. 2023, 12, 4463.
https://doi.org/10.3390/jcm12134463
AMA Style
Moriya K, Sato S, Nishimura N, Kawaratani H, Takaya H, Kaji K, Namisaki T, Uejima M, Nagamatsu S, Matsuo H,
et al. Efficacy of Serum Ferritin–Zinc Ratio for Predicting Advanced Liver Fibrosis in Patients with Autoimmune Hepatitis. Journal of Clinical Medicine. 2023; 12(13):4463.
https://doi.org/10.3390/jcm12134463
Chicago/Turabian Style
Moriya, Kei, Shinya Sato, Norihisa Nishimura, Hideto Kawaratani, Hiroaki Takaya, Kosuke Kaji, Tadashi Namisaki, Masakazu Uejima, Shinsaku Nagamatsu, Hideki Matsuo,
and et al. 2023. "Efficacy of Serum Ferritin–Zinc Ratio for Predicting Advanced Liver Fibrosis in Patients with Autoimmune Hepatitis" Journal of Clinical Medicine 12, no. 13: 4463.
https://doi.org/10.3390/jcm12134463
APA Style
Moriya, K., Sato, S., Nishimura, N., Kawaratani, H., Takaya, H., Kaji, K., Namisaki, T., Uejima, M., Nagamatsu, S., Matsuo, H., & Yoshiji, H.
(2023). Efficacy of Serum Ferritin–Zinc Ratio for Predicting Advanced Liver Fibrosis in Patients with Autoimmune Hepatitis. Journal of Clinical Medicine, 12(13), 4463.
https://doi.org/10.3390/jcm12134463
